Snippet from the press release:
Dr. Gail Naughton, CEO of Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts grown under embryonic conditions, will address attendees tomorrow at the 4th Annual Stem Cell Summit in New York. Dr. Naughton will be presenting preliminary mid-trial results from Histogen’s first human clinical evaluation of ReGenicaTM for hair regrowth.
The primary objective of this double-blind, placebo-controlled, randomized study is to evaluate safety in the clinical application of the ReGenica product for hair regrowth. Histogen is also examining product efficacy as a secondary objective, specifically looking at the same end-points the Company has seen in the animal model – new hair growth, and the thickness of new and existing hair. The study is in progress, but the Company has reviewed data from the scheduled 12 week time point and is pleased with the results to date.
Read the full text — Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit
This is all quite exciting! Until I see actual data it wouldn’t be professional of me to comment further, though. There’s also an article I just found from yesterday with a photo of preliminary results, and they look very promising (see here). The hair count does appear to be increased. Remember, this is all very early clinical trial stuff, but I’ll post more info as it becomes available.